Business
CE Mark for CSD500
CE Mark for CSD500.
About this update from Futura Medical Plc
[{"type":"text","content":"\n \nRNS Number : 9106L Futura Medical PLC 08 August 2011 \n \n\n\n\n\n\nFor immediate release\n\n\n8 August 2011\n\n\n\n\n \n \n \nFutura Medical plc\n(\"Futura\" or \"the Company\")\n \nAward of CSD500 CE mark \nFutura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce the award of the CE mark certificate to Reckitt Benckiser plc for CSD500, the Company's novel condom. The award of the CE mark means that CSD500 can be marketed in 29 European countries and also in a number of non-European territories that recognise the CE mark process. Exclusive worldwide rights to CSD500 are licensed to Reckitt Benckiser plc.\nCSD500 is clinically proven to produce a firmer erection and increase penile size in healthy men whilst wearing a condom during sexual intercourse and give women a longer lasting sexual experience.\nCSD500's intellectual property position has been protected throughout the world, including the principal consumer markets in Europe, the USA and Canada, through patents now granted or proceeding to grant in 36 countries with one remaining application pending.\nJames Barder, Futura's Chief Executive, said: \"The award of the CE mark for CSD500 is a highly significant event in the development of Futura. We look forward to working with Reckitt Benckiser to commercialise CSD500 and to Futura becoming a revenue generating company with a recurring royalty income stream.\"\n \nA Reckitt Benckiser spokesperson said: \"CSD500 is an exciting innovation and we are delighted that the CE mark has been awarded. We are actively evaluating plans to launch a product with CSD500 in the near future.\"\n \n \nFor any further information please contact:\n \n\n\n\n\nFutura Medical plc\n\n\n \n\n\n\n\nJames Barder, Chief Executive\n\n\nTel: +44 (0) 1483 685 670\n\n\n\n\n \n\n\n \n\n\n\n\nmail to: [email protected]\n\n\nwww.futuramedical.com\n\n\n\n\n \n\n\n \n\n\n\n\nNomura Code Securities Limited\n\n\n \n\n\n\n\nPhil Walker / Giles Balleny\n\n\nTel:+44 (0)20 7776 1200\n\n\n\n\n \n\n\n \n\n\n\n\nFor media enquiries please contact:\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nBuchanan Communications\n\n\n \n\n\n\n\nMark Court / Jessica Fontaine\n\n\nTel...